small molecule

IDOSE TR

TRAVOPROST

Loss of exclusivityFebruary 2031latest FDA-listed patent expiry

CompanyGlaukos →View the full company profile on CliffBio

Drug detail

Brand name	IDOSE TR
Active ingredient	TRAVOPROST
Strength	75MCG
Dosage form	IMPLANT
Route	INTRACAMERAL
Modality	Small molecule
FDA approval	December 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
12201555	February 2031	substance, product
11426306	October 2030	product
10206813	October 2030	product
12201557	June 2030	substance, product

Regulatory exclusivity

Code	Expires
NP	December 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Glaukos